We investigated the efficacy of lacrimal punctal occlusion surgery with a cautery device in patients with chronic GVHD (cGVHD) -related dry eye, with recanalization of puncta and recurrent punctal plug extrusion. A total of 23 puncta from 14 eyes of 10 patients with chronic GVHD (cGVHD)-related dry eye underwent punctual thermal cauterization with a high-temperature disposable cautery device. All patients were refractory to conventional treatment, including artificial tear eye drops, autologous serum eye drops and vitamin A eye drops, and had a history of recanalization and recurrent punctal plug extrusion. The effect of lacrimal punctal cauterization by thermal cautery device was evaluated by changes in subjective symptom scores, corrected distance visual acuity, Schirmer's test values, fluorescein staining scores, rose bengal staining scores, and tear-film break-up time before and 3 months after the surgery. Subjective symptom scores, Schirmer's test values, fluorescein and rose bengal scores, and tear-film break-up time improved significantly 3 months after the surgery. Recanalization of puncta was not observed in all the cases (0 of 14 eyes, 0%). Lacrimal punctal cauterization was effective with no recanalization and significant improvements in subjective symptoms and the ocular surface environment in cGVHD-related dry eye patients who had been refractory to conventional treatments.
INTRODUCTION
Ocular complications after hematopoietic SCT (HSCT) occur in approximately 60% of HSCT recipients. 1 The clinical spectrum of chronic ocular GVHD includes chronic conjunctival inflammation, pseudomembranous and cicatricial conjunctivitis and dry eye. 2 Of these complications, dry eye related to cGVHD is frequent, with 50% of patients developing or experiencing worsened pre-existing dry eye after HSCT. 3 In addition to conventional therapies for dry eye, special treatments, such as autologous serum eye drops, topical CYA and topical tranilast have been reported to alleviate dry eye symptoms and to lead to objective improvement. 4 --6 Additional indication of punctal plug insertion for patients insufficiently responding to such treatment was reported to be safe and effective in patients with dry eye related to cGVHD. 7 However, the effect of punctal occlusion by punctal plug is temporary in some cases, because of recurrent plug extrusion or loss. In case of dry eye patients related to cGVHD, the spontaneous plug loss was reported to be happened in 59%, which remained to be a main problem and bothering the recipients after HSCT. 7 On the other hand, surgical treatment aims to provide permanent punctual occlusion for patients with recurrent punctal plug extrusion.
Thermal cauterization, which is one of the surgical punctal occlusion methods, is reported to be very efficient in the management of chronic Stevens --Johnson syndrome and severe dry eye with recurrent punctal plug extrusion, and the reported recanalization rates for these conditions are 26.1% and 1.4%, respectively. 8, 9 Here, we report the effect of lacrimal punctal thermal cauterization with a high-temperature disposable cautery device in patients with cGVHD-related dry eye.
MATERIALS AND METHODS

Subjects and inclusion criteria
A total of 10 patients (7 males and 3 females; median age, 49.1 years; range 34 --62) with severe dry eye related to cGVHD were enrolled in this interventional case series study at the Dry Eye Subspecialty Clinic of the Department of Ophthalmology, Keio University, Tokyo, Japan. This study followed the guidelines of the Declaration of Helsinki. Written informed consent was obtained from all the subjects after explanation of the nature and possible consequence of the study. The Institutional Review Board IRB committee approval was obtained at Keio University (No.2011-168) .
The definition of dry eye was defined according to the Dry Eye Workshop (DEWS) report 2007. 10 Patients with level 3 and 4 in dry eye severity grading were given a diagnosis of severe dry eye.
The eligibility criteria for punctal cauterization were as follows: (1) dry eye refractory to conventional treatment, including artificial tear eye drops, autologous serum eye drops and vitamin A eye drops; (2) temporal clinical improvement was observed during the lacrimal punctum occluded by surgical suturing and tamponade, such as collagen and punctal plug; (3) recanalization of puncta and recurrent punctal plug auto-extrusion; (4) absence of active ophthalmic infections and inflammation or ophthalmic disease other than dry eye, at the time of treatment; (5) absence of active systemic GVHD; and (6) absence of excessive fibrous tissue formation at the site of the scar or injury (that is, no keloidosis).
Surgical procedure
The same surgeon (YO) performed all the surgeries. Two percent lidocaine was injected into the skin and conjunctiva surrounding the punctum, and an infratrochlear nerve block was performed. Using enough anesthesia to block the blink was essential for the patient to make the procedure comfortable. Punctal cauterization was performed using a high-temperature sterile disposable cautery device (Optemp IIV, Alcon Japan, Tokyo, Japan) ( Figure 1 ). This device uses direct electrical current from a battery to heat the U-shaped wire for cauterization. For the occlusion procedure, the tip of the Optemp IIV was inserted into the punctum, so that it was enclosed by and in contact with the walls of the lacrimal canaliculus. Cauterization was initiated and continued until the tissue around the punctum shrank and began to whiten. As the loop of the cautery was still hot immediately after it was turned off, a flow of normal saline was applied around the punctal tissue to cool it, and to the tip of the cautery. The cautery device was then gently removed from the punctum.
Postoperative course/ocular examinations
Following surgery, all patients were treated with topical levofloxacin 0.5% (Cravit, Santen Pharmaceuticals, Osaka, Japan) and ofloxacin ophthalmic ointment 0.3% (Tarivit, Santen Pharmaceuticals) three times daily for 3 days. They were also given cefcapene pivoxil hydrochloride hydrate (Flomox 100 mg, Shionogi & Co., Ltd, Osaka, Japan) and Loxoprofen sodium hydrate (Loxonin 60 mg, Daiichi Sankyo Co., Ltd, Tokyo, Japan) three times daily for the first 3 days after the operation.
Subjective symptom scores, corrected distance visual acuity measurements, Schirmer's test values, fluorescein staining scores, rose bengal staining scores and tear-film break-up times were obtained before and 3 months after the surgery.
Visual analog scale symptom scores. The subjective symptoms were checked using visual analog scale symptom scores. Specific subjective complications were divided into 12 categories, each with a maximum score of 10, which indicates unbearable discomfort and a minimum of 0, which indicates the absence of symptoms. The visual analog symptom scales were prepared as 10 cm lines, showing visible divisions at equal 1 cm intervals, with 0 and 10 as the endpoints of each line. The patients were asked before and after the operation to check a point on the line corresponding to the current condition of their eyes. The average scores of all categories were calculated. 11 Schirmer's test. The standard Schirmer's test without topical anesthesia was performed. Sterilized strips of filter paper (Showa Yakuhin Kako Co. Ltd, Tokyo, Japan) were placed in the lateral canthus away from the cornea and left in place for 5 min. Readings were reported in millimeters of paper wetted during this time. 12 Ocular vital staining score. A preservative-free solution (2 mL) consisting of 1% fluorescein and 1% rose bengal dye was applied to the conjunctival sac with a micropipette. The intensity of fluorescein staining of the cornea was scored from a minimum of 0 to a maximum of 3 points, allocated to the upper, middle and lower cornea, with a maximum possible total score of 9 points. 13, 14 The intensity of rose bengal staining in the cornea and conjunctiva was recorded according to the method of van Bijsterveld, ranging from 0 to 9 points. 15 Tear film break-up time. The standard tear-film break-up time measurement was performed three times, and the measurements were averaged. 13 Biomicroscopic evaluations. Biomicroscopic evaluations using fluorescein staining were performed with an emphasis on determining the amount of healing and epithelialization of the surgical lesion.
Statistical analysis
All data are presented as the mean±s.d. except for age of the patients. Ocular examination results, including subjective symptoms and visual acuity test results, were compared and analyzed by the Wilcoxon matched pairs signed-rank test. GraphPad Instat software version 3.0 (GraphPad Software, Inc, San Diego, CA, USA) was used for statistical analysis. A P valueo.05 was accepted as statistically significant.
RESULTS
Results from the cauterization of 23 puncta from 10 patients are presented in this study. The patients' demographic characteristics are summarized in Table 1 .
The mean postoperative follow-up time was 12.9 months (range, 3 --28 months).
Of the 23 cauterized puncta, all (100%) were epithelialized without recanalization at the final follow up of 12.9 months. Anatomic occlusion of each punctum was verified by examination under a slit-lamp to determine the absence of fluorescein dye backflow. A representative finding from case 7 is shown in Figure 2 . The upper lacrimal punctum was well occluded and epithelialized after punctual thermal cauterization. No complications related to lacrimal punctal cauterization, such as pain, subsequent epiphora and/or granuloma formation, were observed.
The subjective symptom score decreased significantly from 4.5 ± 1.6 to 2.0 ± 1.1 (P ¼ 0.008). The logarithm of the corrected distance visual acuity changed from À0.05 ± 0.08 to À0.09 ± 0.04 (P ¼ 0.361). The fluorescein staining score decreased significantly from 6.1 ± 1.1 points to 1.3 ± 0.8 points (P ¼ 0.001). The rose bengal staining score decreased significantly from 5.6 ± 1.5 points to 2.1±2.0 points (P ¼ 0.002). The tear-film break-up time increased significantly from 2.6±1.2 s to 8.1±2.8 s (P ¼ 0.002) and the Schirmer's test value increased significantly from 1.9 ± 2.1 mm to 6.3 ± 2.6 mm (P ¼ 0.002).
Representative changes in an ocular surface before and after cauterization (case 7) are shown in Figure 3 . Fluorescein and rose Figure 1 . Disposable ophthalmic cautery device. Punctal thermal cauterization was performed using a disposable battery-operated ophthalmic cautery device (a). A wire loop (enlarged at b), which glows red when the direct electrical current is on, transmits heat to the canalicular tissues, cauterizing them.
bengal staining of the ocular surface improved after punctal thermal cauterization.
DISCUSSION
The occlusion of the lacrimal punctum prevents the drainage of natural and artificial tears, thus relieving the objective and subjective symptoms of patients with dry eye. 16 The combination of eye drops and punctal occlusion with punctal plugs have been the main treatment for severe dry eye. Although punctal plug occlusion has been reported to be an efficient method, recurrent plug extrusion or loss remains the main problems of this treatment method. In the patients with recurrent plug extrusion, the duration of puncta occluded by the plugs is rather short. In the treatment of patients with recurrent punctal plug auto-extrusion, surgical punctal occlusion is considered as the final option for severe dry eye. The punctum to which surgical method was applied is anatomically occluded, the effect of occlusion lasts for long time unless it recanalized. Methods used for surgical punctal occlusion include thermal cautery, diathermy, laser coagulation and punctal suturing. 16 --22 Among them, thermal cauterization is reported to be an efficient means to achieve punctal occlusion with a low rate of recanalization. 8, 9, 18 In our case series, thermal cauterization using a high-temperature cautery device was performed for the patients with recurrent plug extrusion. The recanalization rate of cauterization was 0%; average of 12.9 months follow-up assessment disclosed that the puncta to which thermal cautery was applied remained closed significantly longer than those of which punctual plug was applied. Our recanalization rate of 0% is better than that of previous reports.
Three factors probably contributed to our higher success rate of punctal occlusion. First, as the surgical device, we chose a hightemperature sterile disposable cautery device (Optemp IIV). Ohba et al. 9 reported that the tip of the Optemp IIV cautery heats to 105 1C instantly, which is higher than a conventional cautery device. As the device is operated by simply pushing a button, it is easy to manage and to maintain a high temperature. Thus, we were able to reproducibly apply the same manipulation to all the puncta. Representative finding for anatomic punctal occlusion before and after thermal cauterization (case 7). Medial commissure of left eye of case 7. Upper lacrimal punctum before (a; slit-lamp examination) and after (b; slit-lump examination using fluorescein staining) treatment is shown; the arrow indicates the punctum.
The second factor was the surgical procedure. The tip of the Optemp IIV was placed in contact with the tissues during cauterization. The tip is ordinarily inserted into the punctum. In cases where the punctum is invisibly open because of past treatment, such as suture punctual occlusion, the tip is attached to the scarred punctum. The Optemp IIV transmits enough heat to evaporate intra-and extracellular water, kill the cells and cause collagen to retract. The heat delivered by the wire is transmitted to the superficial tissue in contact with it, which is then relayed to deeper tissues. 16 These effects of cauterization highlight the importance of placing the tip of the device in direct contact with the tissues. We think that this mechanism makes it possible to close the very small punctum resulted from the past treatment.
The third factor was the patients' clinical histories. They were all HSCT recipients suffering from cGVHD-related dry eye. In fact, 6.7% of HSCT recipients are reported to show spontaneous lacrimal punctal occlusion. 23 Keratinization of the ductal epithelia due to dry eye, excessive fibrosis around the orifice of the punctum, destruction of the ductal epithelia due to lymphocyte infiltration, sloughing of epithelial cells due to pseudomembrane formation, and infection, alone or in combination, may account for the development of spontaneous lacrimal punctal occlusion after allogenic HSCT. 23 We think the patients' increased predisposition for lacrimal punctal occlusion under surgical inflammation as a result of these ocular pathologies contributed to our higher success rate of punctal occlusion by cauterization for the patients with cGVHD-related dry eye.
The dramatic improvements of subjective symptom scores, Schirmer's test values, the fluorescein scores, the rose bengal scores and tear-film break-up time were observed after the perfect punctum occlusion. Though BCVA was not statistically improved after the surgery, the blurred vision score in the subjective symptoms questionnaire improved from the score before treatment was 2.8±3.6 to after treatment was 1.8±2.0 (Po0.01).
With regard to visual function, Goto et al. 24 reported that the functional visual acuity (FVA), which was measured after sustained eye opening, deteriorated in the dry eye patients and that FVA improved after punctual plug insertion. 25 In the present study, we measured FVA in six eyes of four patients before and after the surgery. The FVA scores, which is the average of all visual acuity values measured over time, improved from 0.18±0.18 to 0.07 ± 0.09 (Po0.1). Though the results of FVA are about limited small numbers of the present study, we think that there will be a correlation between the improvement of the FVA and subjective symptom of blurred vision in all the cases.
In this study, no complications related to punctal cauterization were observed. There was no statistical change in the epiphora score in the subjective symptoms questionnaire from the score before treatment was 2.1±3.5 and that after treatment was 1.7 ± 3.4 (P ¼ NA). We did not expect granuloma formation to occur as a complication of cauterization, as we excluded patients with pre-existing excessive fibrosis (that is, patients with active ophthalmic inflammation/infection, active systemic GVHD and keloidosis).
In conclusion, lacrimal punctal cauterization with a hightemperature disposable cautery device improved objective symptoms and the ocular surface environment in cGVHD-related dry eye. Therefore, in our limited experience, thermal cauterization appears to be a safe and effective therapy for severe dry eye that is not associated with complications or re-canalization. Patients with severe dry eye related to cGVHD who have not responded to conventional treatments mainly because of recurrent plug extrusion would be good candidates for this therapy. 
